Vaxcyte Inc (PCVX) — Financial Flexibility Index
Vaxcyte Inc (PCVX) has a Financial Flexibility Index of -0.75x as of March 2026. Free cash flow of $-265.83 Million (operating CF $-280.62 Million minus capex $14.79 Million) represents -1% of total liabilities ($352.29 Million). Check how strategically is Vaxcyte Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vaxcyte Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Vaxcyte Inc across 9 annual periods. See PCVX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vaxcyte Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Vaxcyte Inc. For the full company profile including market capitalisation, see PCVX market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.78x | $-641.86 Million | $-655.58 Million | $360.45 Million | ▲ +14.9% |
| 2024 | -2.09x | $-430.20 Million | $-452.63 Million | $205.50 Million | ▼ -53.1% |
| 2023 | -1.37x | $-228.91 Million | $-296.79 Million | $167.45 Million | ▲ +56.4% |
| 2022 | -3.13x | $-164.76 Million | $-170.60 Million | $52.56 Million | ▼ -10.0% |
| 2021 | -2.85x | $-114.84 Million | $-121.39 Million | $40.32 Million | ▼ -194.3% |
| 2020 | -0.97x | $-45.47 Million | $-46.63 Million | $46.98 Million | ▼ -262.4% |
| 2019 | -0.27x | $-45.95 Million | $-47.15 Million | $172.07 Million | ▼ -19.6% |
| 2018 | -0.22x | $-28.69 Million | $-30.47 Million | $128.53 Million | ▼ -14022.4% |
| 2017 | 0.00x | $-13.74K | $-14.96K | $8.69 Million | — |